SCHEMBL1868097

SCHEMBL1868097

Cc1cc(S(C)(=O)=O)cc(C)c1S(=O)(=O)NN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
CYP3A4 P08684 1/20 0.39
ACHE P22303 1/20 0.37
CYP1A2 P05177 1/20 0.36
MAPK1 P28482 1/20 0.36
GFER P55789 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422151 0.81 CA1 (0.63) GAAALDH1A1MAPTCA1CA2
SCHEMBL15041660 0.75 LMNA (0.39) GAAALDH1A1KDM4EMAPTMAPK1
SCHEMBL1868304 0.72 TSHR (0.40) ALDH1A1MAPTCA1CA2MMP1
SCHEMBL12098068 0.72 ALDH1A1 (0.46) ALDH1A1MAPTCA1CA2MMP1
Hydrochloric Acid SCHEMBL15619260 0.71 ALDH1A1 (0.44) ALDH1A1MAPTCA1CA2MMP1
SCHEMBL27578218 0.70 SMN1; SMN2 (0.55) GAAALDH1A1CA1CA2MMP1
SCHEMBL1864223 0.69 LMNA (0.55) ALDH1A1MAPTMAPK1GFERPOLB
SCHEMBL11526686 0.69 CYP1A2 (0.50) GAAALDH1A1KDM4EMAPTCA1
SCHEMBL1577443 0.67 CA1 (0.48) GAAALDH1A1KDM4EMAPTCA1
SCHEMBL2437905 0.67 G6PD (0.41) GAAMAPTCA1CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120232072-A1 IMIDAZOPYRIDINE DERIVATIVES PIRAMAL LIFE SCIENCES LIMITED (IN) 2012-09-13 US claimed
US-8741932-B2 Imidazopyridine derivatives Piramal Enterprises Limited (IN) 2014-06-03 US disclosed
US-20120232072-A1 IMIDAZOPYRIDINE DERIVATIVES PIRAMAL LIFE SCIENCES LIMITED (IN) 2012-09-13 US disclosed
EP-2496577-A1 IMIDAZOPYRIDINE DERIVATIVES Piramal Life Sciences Limited (IN) 2012-09-12 EP disclosed
WO-2011055320-A1 IMIDAZOPYRIDINE DERIVATIVES PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232072-A1 IMIDAZOPYRIDINE DERIVATIVES IL6, IL6ST, STAT3 GAA 3172/4885ALDH1A1 2629/4885KDM4E 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.